226 related articles for article (PubMed ID: 25339355)
1. Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy.
Aouizerate J; De Antonio M; Bassez G; Gherardi RK; Berenbaum F; Guillevin L; Berezne A; Valeyre D; Maisonobe T; Dubourg O; Cosnes A; Benveniste O; Authier FJ
Acta Neuropathol Commun; 2014 Oct; 2():154. PubMed ID: 25339355
[TBL] [Abstract][Full Text] [Related]
2. Distinct interferon signatures stratify inflammatory and dysimmune myopathies.
Rigolet M; Hou C; Baba Amer Y; Aouizerate J; Periou B; Gherardi RK; Lafuste P; Authier FJ
RMD Open; 2019; 5(1):e000811. PubMed ID: 30886734
[TBL] [Abstract][Full Text] [Related]
3. Muscle pathology of antisynthetase syndrome according to antibody subtypes.
Tanboon J; Inoue M; Hirakawa S; Tachimori H; Hayashi S; Noguchi S; Okiyama N; Fujimoto M; Suzuki S; Nishino I
Brain Pathol; 2023 Jul; 33(4):e13155. PubMed ID: 36882048
[TBL] [Abstract][Full Text] [Related]
4. C5b-9 deposits on endomysial capillaries in non-dermatomyositis cases.
Braczynski AK; Harter PN; Zeiner PS; Drott U; Tews DS; Preusse C; Penski C; Dunst M; Weis J; Stenzel W; Mittelbronn M
Neuromuscul Disord; 2016; 26(4-5):283-91. PubMed ID: 27020463
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
Merlonghi G; Antonini G; Garibaldi M
Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
[TBL] [Abstract][Full Text] [Related]
6. [Inflammatory myopathies: diagnosis and classifications].
Dimitri D
Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
[TBL] [Abstract][Full Text] [Related]
7. RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.
Suárez-Calvet X; Gallardo E; Pinal-Fernandez I; De Luna N; Lleixà C; Díaz-Manera J; Rojas-García R; Castellví I; Martínez MA; Grau JM; Selva-O'Callaghan A; Illa I
Arthritis Res Ther; 2017 Jul; 19(1):174. PubMed ID: 28738907
[TBL] [Abstract][Full Text] [Related]
8. Class I MHC detection as a diagnostic tool in noninformative muscle biopsies of patients suffering from dermatomyositis (DM).
Civatte M; Schleinitz N; Krammer P; Fernandez C; Guis S; Veit V; Pouget J; Harlé JR; Pellissier JF; Figarella-Branger D
Neuropathol Appl Neurobiol; 2003 Dec; 29(6):546-52. PubMed ID: 14636161
[TBL] [Abstract][Full Text] [Related]
9. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
Das L; Blumbergs PC; Manavis J; Limaye VS
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
[TBL] [Abstract][Full Text] [Related]
10. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
11. Sarcoplasmic MxA expression: A valuable marker of dermatomyositis.
Uruha A; Nishikawa A; Tsuburaya RS; Hamanaka K; Kuwana M; Watanabe Y; Suzuki S; Suzuki N; Nishino I
Neurology; 2017 Jan; 88(5):493-500. PubMed ID: 28039312
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory myopathy with abundant macrophages and dermatomyositis: two stages of one disorder or two distinct entities?
Brunn A; Hans VJ; Vogelgesang S; Deckert M
Acta Neuropathol; 2009 Dec; 118(6):793-801. PubMed ID: 19590880
[TBL] [Abstract][Full Text] [Related]
13. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features of graft versus host disease-associated myositis.
Kazuta T; Murakami A; Noda S; Hirano S; Kito H; Tsujikawa K; Nakanishi H; Kimura S; Sahashi K; Koike H; Katsuno M
Ann Clin Transl Neurol; 2024 Feb; 11(2):508-519. PubMed ID: 38152056
[TBL] [Abstract][Full Text] [Related]
15. Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies.
Illa I; Gallardo E; Gimeno R; Serrano C; Ferrer I; Juárez C
Am J Pathol; 1997 Jul; 151(1):81-8. PubMed ID: 9212734
[TBL] [Abstract][Full Text] [Related]
16. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders.
Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau-Junyent JM; Christopher-Stine L; Corse AM; Mammen AL
Rheumatology (Oxford); 2023 Sep; 62(9):3156-3160. PubMed ID: 36707996
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of FAS and FAS ligand in inflammatory myopathies.
De Bleecker JL; Meire VI; Van Walleghem IE; Groessens IM; Schröder JM
Acta Neuropathol; 2001 Jun; 101(6):572-8. PubMed ID: 11515785
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression in idiopathic inflammatory myopathies at a single center in Vietnam.
Ngo DQ; Le ST; Phan KHP; Doan TTP; Nguyen LNK; Dang MH; Ly TT; Phan TDA
J Pathol Transl Med; 2024 Jun; ():. PubMed ID: 38910358
[TBL] [Abstract][Full Text] [Related]
19. Differential immunohistological features of inflammatory myopathies and dysferlinopathy.
Choi JH; Park YE; Kim SI; Kim JI; Lee CH; Park KH; Kim DS
J Korean Med Sci; 2009 Dec; 24(6):1015-23. PubMed ID: 19949654
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
